Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 Feb;37(2):173–179. doi: 10.1111/j.1365-2125.1994.tb04257.x

Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery.

G W He 1, T E Acuff 1, W H Ryan 1, C Q Yang 1, M B Douthit 1, R T Bowman 1, M J Mack 1
PMCID: PMC1364594  PMID: 7910471

Abstract

1. The internal mammary artery has become a preferred coronary bypass graft. Sympathomimetic amines are spasmogens for vasospasm and calcium antagonists are frequently administered drugs perioperatively. The effect of calcium antagonists on alpha-adrenoceptor-mediated contraction depends on the subtype of alpha-adrenoceptor and the type of origin of vascular smooth muscle. This study was designed to investigate the effect of calcium antagonists on alpha-adrenoceptor-mediated contraction in the IMA. 2. Human IMA segments taken from 22 patients undergoing IMA--coronary artery bypass grafting were mounted in an organ bath under the physiological pressure determined from their own length-tension curves. 3. Three ring segments were allocated into three groups. One served as a control and the others were treated with clinically related concentrations of nifedipine (20 or 200 nM) for 25 min before concentration-contraction curves to alpha 1-adrenoceptor agonist methoxamine (MO) or full alpha-adrenoceptor agonist noradrenaline (NA) were established. 4. In separate experiments, the concentration-relaxation curves to nifedipine were established in the IMA rings precontracted with MO (30 microM) or NA (10 microM). Glyceryl trinitrate (GTN, 3 microM) was added to further relax the vessels. 5. Pretreatment with nifedipine (200 nM) only slightly inhibited the MO- (1.74 +/- 0.32 vs 2.88 +/- 0.56 g) or NA- (2.43 +/- 0.66 vs 3.60 +/- 0.82 g) induced contraction without statistical significance (P > 0.05). 6. On the other hand, nifedipine only caused 34.49% relaxation in the MO-precontracted and 24.39% relaxation in the NA-precontracted IMAs. In contrast, GTN caused 76.16% (against MO, P < 0.05) or 92.22% (against NA, P < 0.0001) relaxation.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angus J. A., Cocks T. M., Satoh K. Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol. 1986 Aug;88(4):767–777. doi: 10.1111/j.1476-5381.1986.tb16249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ariëns E. J., Simonis A. M. Physiological and pharmacological aspects of adrenergic receptor classification. Biochem Pharmacol. 1983 May 15;32(10):1539–1545. doi: 10.1016/0006-2952(83)90324-6. [DOI] [PubMed] [Google Scholar]
  3. Barner H. B., Standeven J. W., Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg. 1985 Nov;90(5):668–675. [PubMed] [Google Scholar]
  4. Griffiths J. R., Iles R. A. Nuclear magnetic resonance--a 'magnetic eye' on metabolism. Clin Sci (Lond) 1980 Oct;59(4):225–230. doi: 10.1042/cs0590225. [DOI] [PubMed] [Google Scholar]
  5. Hamilton C. A., Jardine E., Sumner D. J., Reid J. L. The effects of calcium antagonists on blood pressure and responses to alpha-adrenoceptor agonists in hypertensive rabbits. Clin Exp Pharmacol Physiol. 1987 Feb;14(2):77–85. doi: 10.1111/j.1440-1681.1987.tb00960.x. [DOI] [PubMed] [Google Scholar]
  6. He G. W., Angus J. A., Rosenfeldt F. L. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol. 1988 Jul;12(1):12–22. doi: 10.1097/00005344-198807000-00003. [DOI] [PubMed] [Google Scholar]
  7. He G. W., Buxton B., Rosenfeldt F. L., Wilson A. C., Angus J. A. Weak beta-adrenoceptor-mediated relaxation in the human internal mammary artery. J Thorac Cardiovasc Surg. 1989 Feb;97(2):259–266. [PubMed] [Google Scholar]
  8. He G. W., Shaw J., Hughes C. F., Yang C. Q., Thomson D. S., McCaughan B., Hendle P. N., Baird D. K. Predominant alpha 1-adrenoceptor-mediated contraction in the human internal mammary artery. J Cardiovasc Pharmacol. 1993 Feb;21(2):256–263. [PubMed] [Google Scholar]
  9. He G. W., Shaw J., Yang C. Q., Hughes C., Thomson D., McCaughan B., Hendle P. N., Baird D. K. Inhibitory effects of glyceryl trinitrate on alpha-adrenoceptor mediated contraction in the human internal mammary artery. Br J Clin Pharmacol. 1992 Sep;34(3):236–243. doi: 10.1111/j.1365-2125.1992.tb04130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henry P. D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol. 1980 Dec 1;46(6):1047–1058. doi: 10.1016/0002-9149(80)90366-5. [DOI] [PubMed] [Google Scholar]
  11. Heusch G. Alpha-adrenergic mechanisms in myocardial ischemia. Circulation. 1990 Jan;81(1):1–13. doi: 10.1161/01.cir.81.1.1. [DOI] [PubMed] [Google Scholar]
  12. Hicks P. E., Tierney C., Langer S. Z. Preferential antagonism by diltiazem of alpha 2-adrenoceptor mediated vasoconstrictor responses in perfused tail arteries of spontaneous hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):388–395. doi: 10.1007/BF00692906. [DOI] [PubMed] [Google Scholar]
  13. Houghton J. L., Callaghan W. E., Frank M. J. Disappearance of high-grade left anterior descending stenosis after revascularization. Cathet Cardiovasc Diagn. 1988;14(3):169–171. doi: 10.1002/ccd.1810140307. [DOI] [PubMed] [Google Scholar]
  14. Högestätt E. D., Andersson K. E., Edvinsson L. Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit. Acta Physiol Scand. 1982 Feb;114(2):283–296. doi: 10.1111/j.1748-1716.1982.tb06984.x. [DOI] [PubMed] [Google Scholar]
  15. Janis R. A., Triggle D. J. New developments in Ca2+ channel antagonists. J Med Chem. 1983 Jun;26(6):775–785. doi: 10.1021/jm00360a001. [DOI] [PubMed] [Google Scholar]
  16. Jett G. K., Guyton R. A., Hatcher C. R., Jr, Abel P. W. Inhibition of human internal mammary artery contractions. An in vitro study of vasodilators. J Thorac Cardiovasc Surg. 1992 Oct;104(4):977–982. [PubMed] [Google Scholar]
  17. Jie K., van Brummelen P., Timmermans P. B., Thoolen M. J., van Zwieten P. A. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat. Arch Int Pharmacodyn Ther. 1985 Nov;278(1):72–86. [PubMed] [Google Scholar]
  18. Kannan M. S., Seip A. E. Mechanisms of alpha-adrenoceptor mediated contractions of rat mesenteric artery. Can J Physiol Pharmacol. 1986 Apr;64(4):419–423. doi: 10.1139/y86-067. [DOI] [PubMed] [Google Scholar]
  19. Langer S. Z., Hicks P. E. Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. J Cardiovasc Pharmacol. 1984;6 (Suppl 4):S547–S558. doi: 10.1097/00005344-198406004-00001. [DOI] [PubMed] [Google Scholar]
  20. Loop F. D., Lytle B. W., Cosgrove D. M., Stewart R. W., Goormastic M., Williams G. W., Golding L. A., Gill C. C., Taylor P. C., Sheldon W. C. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986 Jan 2;314(1):1–6. doi: 10.1056/NEJM198601023140101. [DOI] [PubMed] [Google Scholar]
  21. Lytle B. W., Loop F. D., Cosgrove D. M., Ratliff N. B., Easley K., Taylor P. C. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985 Feb;89(2):248–258. [PubMed] [Google Scholar]
  22. Medgett I. C., Langer S. Z. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. J Pharmacol Exp Ther. 1984 Jun;229(3):823–830. [PubMed] [Google Scholar]
  23. Mikkelsen E., Andersson K. E., Lederballe Pedersen O. Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins. Acta Pharmacol Toxicol (Copenh) 1979 Feb;44(2):110–119. doi: 10.1111/j.1600-0773.1979.tb02304.x. [DOI] [PubMed] [Google Scholar]
  24. Moxley R. T., 3rd, Kingston W., Griggs R. C. Abnormal regulation of venous alanine after glucose ingestion in myotonic dystrophy. Clin Sci (Lond) 1985 Feb;68(2):151–157. doi: 10.1042/cs0680151. [DOI] [PubMed] [Google Scholar]
  25. Müller-Schweinitzer E. Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine. Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):64–69. doi: 10.1007/BF00647840. [DOI] [PubMed] [Google Scholar]
  26. Nakashima A., Angus J. A., Johnston C. I. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol. 1982 Jul 16;81(3):487–492. doi: 10.1016/0014-2999(82)90114-5. [DOI] [PubMed] [Google Scholar]
  27. Sarabu M. R., McClung J. A., Fass A., Reed G. E. Early postoperative spasm in left internal mammary artery bypass grafts. Ann Thorac Surg. 1987 Aug;44(2):199–200. doi: 10.1016/s0003-4975(10)62041-3. [DOI] [PubMed] [Google Scholar]
  28. Schoeffter P., Dion R., Godfraind T. Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery. Br J Pharmacol. 1988 Oct;95(2):531–543. doi: 10.1111/j.1476-5381.1988.tb11674.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sims F. H. A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosis. Am Heart J. 1983 Apr;105(4):560–566. doi: 10.1016/0002-8703(83)90478-7. [DOI] [PubMed] [Google Scholar]
  30. Singh R. N., Sosa J. A., Green G. E. Long-term fate of the internal mammary artery and saphenous vein grafts. J Thorac Cardiovasc Surg. 1983 Sep;86(3):359–363. [PubMed] [Google Scholar]
  31. Van Meel J. C., De Jonge A., Kalkman H. O., Wilffert B., Timmermans P. B., Van Zwieten P. A. Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol. 1981 Jan 16;69(2):205–208. doi: 10.1016/0014-2999(81)90415-5. [DOI] [PubMed] [Google Scholar]
  32. Vanhoutte P. M., Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 1989 Jul;80(1):1–9. doi: 10.1161/01.cir.80.1.1. [DOI] [PubMed] [Google Scholar]
  33. Yasue H., Touyama M., Kato H., Tanaka S., Akiyama F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J. 1976 Feb;91(2):148–155. doi: 10.1016/s0002-8703(76)80568-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES